UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		20,027,065
Beginning balance at Dec. 31, 2022	$ 63,306	$ 20	$ 733,437	$ (670,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	608		608
5-Year Private Warrants transferred to 5-Year Public Warrants – Notes 14 and 15	531		531
Net loss	(13,909)			(13,909)
Ending balance (in shares) at Mar. 31, 2023		20,027,065
Ending balance at Mar. 31, 2023	50,536	$ 20	734,576	(684,060)
Beginning balance (in shares) at Dec. 31, 2022		20,027,065
Beginning balance at Dec. 31, 2022	63,306	$ 20	733,437	(670,151)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(43,510)
Ending balance (in shares) at Sep. 30, 2023		20,213,282
Ending balance at Sep. 30, 2023	22,579	$ 20	736,220	(713,661)
Beginning balance (in shares) at Mar. 31, 2023		20,027,065
Beginning balance at Mar. 31, 2023	50,536	$ 20	734,576	(684,060)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	952		952
5-Year Private Warrants transferred to 5-Year Public Warrants – Notes 14 and 15	15		15
Vesting of restricted stock units (in shares)		168,336
Vesting of restricted stock units	0		0
Net loss	(13,889)			(13,889)
Ending balance (in shares) at Jun. 30, 2023		20,195,401
Ending balance at Jun. 30, 2023	37,614	$ 20	735,543	(697,949)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation costs	640		640
5-Year Private Warrants transferred to 5-Year Public Warrants – Notes 14 and 15	37		37
Vesting of restricted stock units (in shares)		17,881
Vesting of restricted stock units	0		0
Net loss	(15,712)			(15,712)
Ending balance (in shares) at Sep. 30, 2023		20,213,282
Ending balance at Sep. 30, 2023	22,579	$ 20	736,220	(713,661)
Beginning balance (in shares) at Dec. 31, 2023		20,736,612
Beginning balance at Dec. 31, 2023	12,656	$ 21	737,810	(725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		517,688
Issuance of common stock – Note 15	1,160		1,160
Stock-based compensation costs	679		679
Vesting of restricted stock units (in shares)		2,595
Net loss	(20,749)			(20,749)
Ending balance (in shares) at Mar. 31, 2024		21,256,895
Ending balance at Mar. 31, 2024	(6,254)	$ 21	739,649	(745,924)
Beginning balance (in shares) at Dec. 31, 2023		20,736,612
Beginning balance at Dec. 31, 2023	12,656	$ 21	737,810	(725,175)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(48,158)
Ending balance (in shares) at Sep. 30, 2024		24,132,592
Ending balance at Sep. 30, 2024	(23,134)	$ 21	750,177	(773,332)
Beginning balance (in shares) at Mar. 31, 2024		21,256,895
Beginning balance at Mar. 31, 2024	(6,254)	$ 21	739,649	(745,924)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		2,474,859
Issuance of common stock – Note 15	8,898		8,898
Stock-based compensation costs	801		801
5-Year Private Warrants transferred to 5-Year Public Warrants – Notes 14 and 15	5		5
Vesting of restricted stock units (in shares)		290,397
Net loss	(13,180)			(13,180)
Ending balance (in shares) at Jun. 30, 2024		24,022,151
Ending balance at Jun. 30, 2024	(9,730)	$ 21	749,353	(759,104)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and warrants (in shares)		89,118
Issuance of common stock – Note 15	220		220
Stock-based compensation costs	604		604
Vesting of restricted stock units (in shares)		21,323
Vesting of restricted stock units			0
Net loss	(14,228)			(14,228)
Ending balance (in shares) at Sep. 30, 2024		24,132,592
Ending balance at Sep. 30, 2024	$ (23,134)	$ 21	$ 750,177	$ (773,332)